• HTA176 Health Technology Assessments of Oncology Orphan and Advanced Therapies: The Case for Incorporating Real-World Evidence Patient-Reported Outcomes and Indirect Treatment Comparisons Into Joint Clinical Assessment Submissions

    Dec 1, 2025, 00:00

  • EE244 Cost-Effectiveness of Delgocitinib vs. PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema

    Dec 1, 2025, 00:00

  • SA64 Mapping Disease-Specific Patient-Reported Outcome Measures (PROMs) to EQ-5D Utility Scores: A Systematic Review

    Dec 1, 2025, 00:00

  • HSD46 Evaluating the Digital Transformation in Healthcare: Adoption, Challenges, and Opportunities

    Dec 1, 2025, 00:00

  • HPR157 Paying for Advanced Therapy Medicinal Products: Are Spreading Payments Over Time the Solution?

    Dec 1, 2025, 00:00

  • PCR78 Establishing the Relationship Between the Worst Itch Numerical Rating Scale and EQ-5D Utility in Patients With Primary Biliary Cholangitis Experiencing Pruritus: Pooled Results From GLIMMER and the PRO Validation Study

    Dec 1, 2025, 00:00

  • EE507 Healthcare Resource Utilization in Patients With Hidradenitis Suppurativa Using Adelphi Real-World Data From EU5 and US

    Dec 1, 2025, 00:00

  • RWD162 Real-World Patient Characteristics and Outcomes Associated With Antibody Drug Conjugate Therapy: A Large Cohort Study

    Dec 1, 2025, 00:00

  • EE108 Budget Impact of Introducing Accuchek® Smartguide Real-Time Continuous Glucose Monitoring (RtCGM) Solution for Diabetes Management in Portugal

    Dec 1, 2025, 00:00

  • PCR252 Triangulation Method to Detect Meaningful Deterioration in Patient's Autonomy Using the New Multiple Sclerosis Autonomy Scale (MSAS) Questionnaire

    Dec 1, 2025, 00:00

  • EE560 Introducing the Parameter Outcome Overview Plot: A New Addition to the Sensitivity Analysis Armory for Economic Models

    Dec 1, 2025, 00:00

  • EE478 Foregone Net Monetary Benefit From Underdiagnosis and Undertreatment of Mild Cognitive Impairment Due to Alzheimer’s Disease in the Medicare Population

    Dec 1, 2025, 00:00

  • EPH44 Chronic Kidney Disease in Type-2 Diabetes Patients: A Population-Based Descriptive Study

    Dec 1, 2025, 00:00

  • EPH41 Characteristics Associated With Having an Activity of Daily Living Limitation (ADLL) or Instrumental Activity of Daily Living Limitation (IADLL) Among US Adults With Asthma

    Dec 1, 2025, 00:00

  • Cost-Effectiveness of Interventions Addressing Loneliness Among Adults: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE398 Economic Impact of Faricimab in Neovascular Age-Related Macular Degeneration Management in France

    Dec 1, 2025, 00:00

  • CO154 Infective Endocarditis Following FRANCE-TAVI Insights

    Dec 1, 2025, 00:00

  • PCR128 Impact of Cancer on the Burden of Caregiving in China, Japan, and EU5: National Health and Wellness Survey

    Dec 1, 2025, 00:00

  • EE573 Markov Model-Based Cost-Effectiveness Evaluation of ROSA® vs. Manual Total Knee Arthroplasty: Sweden Payer Perspective

    Dec 1, 2025, 00:00

  • PCR235 The Life With Amyotrophic Lateral Sclerosis: Socioeconomic Impact of the Disease on Patients and Their Caregivers in the Czech Republic

    Dec 1, 2025, 00:00

  • PCR84 Evaluating the Role of Patient-Reported Outcomes in Phase 4 Clinical Trials: Trends, Applications, and Implications for Postmarketing Surveillance

    Dec 1, 2025, 00:00

  • HTA1 Inefficiencies in Developing UK and Irish HTA Submissions and How to Streamline the Process

    Dec 1, 2025, 00:00

  • EE440 Evaluating the Economic Benefit of Improved High-Dose Influenza Vaccine Coverage in the Elderly Population of Tokyo, Japan

    Dec 1, 2025, 00:00

  • EE18 A Health Economic Evaluation Framework for Implementing a Digital Survivorship Passport for Childhood Cancer Survivors

    Dec 1, 2025, 00:00

  • EE737 Treatment Patterns of Rare Immunodeficiencies With Special Regard to Antibiotics: A German Claims Data Analysis

    Dec 1, 2025, 00:00

  • EE269 Cost-Effectiveness of Proton Beam Therapy in the Treatment of Pediatric Medulloblastoma in France

    Dec 1, 2025, 00:00

  • MSR27 Analysis and Characterization of Variations in Conceptual and Operational Definitions for GLP-1 Agonist Treatment Eligibility for Weight Management

    Dec 1, 2025, 00:00

  • HPR235 Utilization of Glucagon-Like Peptide-1 Receptor Agonists in the Irish Healthcare System

    Dec 1, 2025, 00:00

  • HTA165 Global Adoption of Dynamic Transmission Models in Infectious Disease Vaccine Submissions: A Comparative Analysis Across the EU5 North America and Scandinavia

    Dec 1, 2025, 00:00

  • MSR178 Quantifying the Value of Delaying Type 1 Diabetes Progression: A New Cost-Effectiveness Model for Capturing the Value of Delayed Onset

    Dec 1, 2025, 00:00

  • EE564 Lessons From the NHS AI Awards: Experience of Evaluating AI Tools in Real-World Environments

    Dec 1, 2025, 00:00

  • PCR131 Impact of Nontransfusion-Dependent Thalassemia on Adult Patients' Health-Related Quality of Life and Work Productivity in the Kingdom of Saudi Arabia and United Arab Emirates

    Dec 1, 2025, 00:00

  • EE133 Clinical Management and Outcomes of Patients in England With eGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Observational Study and Its Impact on UK Health Technology Assessments

    Dec 1, 2025, 00:00

  • PCR71 English Translation, Cross-Cultural Adaptation and Validation of the French New Patient-Reported Outcome Measures of the Multiple Sclerosis Autonomy Scale (MSAS)

    Dec 1, 2025, 00:00

  • EE648 Repeated Breast Surgery After a Lumpectomy in England

    Dec 1, 2025, 00:00

  • EPH212 Severity of COVID-19 Pre- and Post-Omicron Emergence in Pediatric Patients: A Global Systematic Literature Review

    Dec 1, 2025, 00:00

  • RWD6 A Record-Level Risk Metric for Partially Synthetic Clinical Data Using Inverse-Square Similarity Decay

    Dec 1, 2025, 00:00

  • RWD190 Use of RWE in HTA Submissions: A Systematic Review of Case Studies Across Three HTA Agencies Reveals Continued Concerns Around Internal Validity and Unmeasured Confounding

    Dec 1, 2025, 00:00

  • EE258 Cost-Effectiveness of Levofloxacin for Tuberculosis Prevention in MDR/RR-TB Contacts in High-Burden Settings

    Dec 1, 2025, 00:00

  • HPR149 Negotiated Closed Budgets in Gree A Case Study of Success in Enhancing Patient Access Whilst Achieving Savings

    Dec 1, 2025, 00:00

  • HTA339 Transparency Tested: Conflict of Interest in EU HTA

    Dec 1, 2025, 00:00

  • EE178 Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia in Brazil

    Dec 1, 2025, 00:00

  • CO156 Investigating Composite Response Definitions Based on Key Surrogate Markers for Predicting Clinical Outcomes in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis

    Dec 1, 2025, 00:00

  • RWD153 Real-World Evidence in Action: Assessing Drug-Drug Interactions to Drive Value-Based Decisions

    Dec 1, 2025, 00:00

  • EE66 Assessing Treatment Efficiency Indicated in Rare Diseases: Learning From the CEESP Has Economic Opinions

    Dec 1, 2025, 00:00

  • HPR133 Longitudinal Trends in Biosimilar Uptake in France 2019-2024: Insights by Dispensing Pathway and Prescribing Origin

    Dec 1, 2025, 00:00

  • HPR205 The Implementation of the European Charter of Patients’ Rights in Hungarian and Romanian Healthcare Legislation With Special Emphasis on Informed Consent

    Dec 1, 2025, 00:00

  • EE307 Cost-Utility Analysis of Pegunigalsidase Alfa Compared to Agalsidase Alfa and Agalsidase Beta for the Treatment of Adult Patients With Fabry Disease in Greece

    Dec 1, 2025, 00:00

  • RWD133 Parental Vaccine Hesitancy in Children With Comorbidities: A Comparative Analysis

    Dec 1, 2025, 00:00

  • EPH165 Monitoring the Burden of Lung Cancer in Germany: Trends in Incidence and Survival Using ZfKD Registry Data 2020-2023

    Dec 1, 2025, 00:00

  • CO143 Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection

    Dec 1, 2025, 00:00

  • PT7 The Association Between Average Sales Price Decline and Shortages in Small Molecule Injectable Oncology Therapies With Generic Competition

    Dec 1, 2025, 00:00

  • HPR44 Citizens’ Send Messages to Policy Makers Related to Primary Healthcare Practices: First Results From the Implementation of the Patient-Reported Indicator Surveys PaRIS in Greece

    Dec 1, 2025, 00:00

  • EE119 Burden of Schizophrenia on the Brazilian Public Healthcare System: A Cost and Service Analysis

    Dec 1, 2025, 00:00

  • EPH191 Prevalence of Migraine in India: A Meta-Analysis With Subgroup Analyses by Population Type

    Dec 1, 2025, 00:00

  • HTA204 Institutional Profiles and the Likelihood of Unfavorable Submissions in Public Consultations on Breast Cancer Drugs in Brazil’s Supplementary Health System

    Dec 1, 2025, 00:00

  • HTA10 A New Approach for Modeling the Complexity of the Impact of Caring Using the Family and Caregiving Effects

    Dec 1, 2025, 00:00

  • MT41 The Role of Flexible Cysto-Nephroscope in Enhancing Stone-Free Rates of Percutaneous Nephrolithotomy: A Global Survey

    Dec 1, 2025, 00:00

  • HPR238 What Does the New ILAP Refresh Mean for Pharmaceutical Development and Patient Access in the UK?

    Dec 1, 2025, 00:00

  • EPH112 Food and Health Literacy Among University Students: Sociodemographic Insights

    Dec 1, 2025, 00:00

  • EE644 Reducing the Transmission and Annual Burden of Influenza in the UK With Baloxavir Marboxil: A Cost-Effectiveness Analysis Using Evidence From the CENTERSTONE Trial

    Dec 1, 2025, 00:00

  • EE301 Cost-Utility Analysis Of Erdosteine for the Prevention of Exacerbations in Patients With COPD in the Czech Republic

    Dec 1, 2025, 00:00

  • EE654 Risk, Time in Hospital, and Associated Costs? of Hospitalizations in Individuals With Infantile-Onset SMA: Results From DEVOTE Part B

    Dec 1, 2025, 00:00

  • EPH16 Analysis of the Epidemiological Disease Burden of Endometriosis in Hungary Based on Data From the Global Burden of Disease Study

    Dec 1, 2025, 00:00

  • PCR136 Improving the Conceptual Coverage of the 15-item Penn Parkinson’s Daily Activity Questionnaire (PDAQ-15) for Use in the Mild-to-Moderate Lewy Body Dementia Population

    Dec 1, 2025, 00:00

  • EE57 Assessing Public Health and Economic Benefits of Nirsevimab or RSVpreF for Preventing RSV-Related Outcomes in Japanese Infants

    Dec 1, 2025, 00:00

  • EPH63 Disease Burden of MASH/MASLD Among People With Obesity in China, Japan, and EU5

    Dec 1, 2025, 00:00

  • EE416 Estimated Long-Term Healthcare Cost Savings From EVP Use in the UK

    Dec 1, 2025, 00:00

  • PCR140 Integrating Patient-Reported Outcome Measures and Patient Experience Into Health Technology Assessment: A Path Towards Patient-Centered Decision Making

    Dec 1, 2025, 00:00

  • PCR56 Describing the Burden of RSV Infection and Subsequent Wheezing in Toddlers: An International Cross-Sectional Study

    Dec 1, 2025, 00:00

  • EE125 Climate Impact of CAR-T Cell Therapy in the Netherlands: A Comparison on the Use Phase Emission Between Standard of Care and CAR-T Cell Therapy in Hemato-oncology

    Dec 1, 2025, 00:00

  • EE386 Economic Evaluation of Synovial Biopsy-Guided Treatment Strategy After TNF-Alpha Inhibitor Failure in Rheumatoid Arthritis

    Dec 1, 2025, 00:00

  • HTA47 Assessment of Severity Modifiers vs. End-of-Life Criteria in Oncology

    Dec 1, 2025, 00:00

  • EE140 Comparative Health Economic Evaluation of Alzheimer’s Diagnostic Treatment Strategies in the Era of Amyloid-Targeting Therapies: A Conceptual Model Framework

    Dec 1, 2025, 00:00

  • CO195 Qualitative Exit Interviews in Charcot-Marie-Tooth Type-2 Sorbitol Dehydrogenase (CMT-SORD) Deficiency

    Dec 1, 2025, 00:00

  • HTA5 A Cross-Sectional Analysis of Early Access Programs in NICE Health Technology Assessments

    Dec 1, 2025, 00:00

  • HTA100 Cost-Utility Analysis of Including X-linked Adrenoleukodystrophy in the Spanish Newborn Screening Program

    Dec 1, 2025, 00:00

  • RWD8 Accelerating HEOR Using Petri Net-Based Simulation Informed by Real-World Data

    Dec 1, 2025, 00:00

  • HPR164 Prices And Reimbursement Conditions for Poly (ADP-RIBOSE) Polymerase Inhibitors (PARPi) Indicated for Ovarian Cancer in Spain

    Dec 1, 2025, 00:00

  • MSR14 Advancing Multiple System Atrophy Diagnosis: Combining AI and Decision Analysis

    Dec 1, 2025, 00:00

  • HTA313 The Acceptability of Wearables in Remote Monitoring According to Health Technology Assessment HTA Bodies

    Dec 1, 2025, 00:00

  • HTA59 Budget Impact Analysis Of Migalastat Incorporation vs. Enzyme Replacement Therapies For Fabry Disease: Validation of a Cost-Assessment Tool In Brazilian Private Healthcare System

    Dec 1, 2025, 00:00

  • PCR187 Population-Level Impact of Emicizumab in Algeria: A 25-Year Projection

    Dec 1, 2025, 00:00

  • EE359 Economic Burden of COVID-19-Related Hospitalizations in Finland: A 4-year Longitudinal Analysis

    Dec 1, 2025, 00:00

  • PCR176 Patient Perspectives on Unmet Needs in mCRPC: Emphasizing Improved Quality of Life and Delay in Chemotherapy

    Dec 1, 2025, 00:00

  • EE383 Economic Evaluation of Second-Generation Colon Capsule Endoscopy for Investigation of the Colon Through Direct Visualization

    Dec 1, 2025, 00:00

  • CO258 US Population-Level Clinical Impact of Lorlatinib Treatment on ALK+ Metastatic Non-Small Cell Lung Cancer Outcomes

    Dec 1, 2025, 00:00

  • MSR153 Natural Language Processing Solution (REALLI) to Evaluate the Limitations of the French National Health Insurance Database (SNDS): Example of HER2+ Metastatic Breast Cancer

    Dec 1, 2025, 00:00

  • RWD37 Comorbidities As a Risk Predictor of Kidney Disease Progression Among Patients Diagnosed With Chronic Kidney Disease

    Dec 1, 2025, 00:00

  • SA44 From Participation to Partnership: Advancing Patient-Centric Inclusive and Equitable Evidence Generation in HEOR

    Dec 1, 2025, 00:00

  • PCR233 The Impact of Treatment Compliance on Healthcare Resource Utilization Amongst Kidney Transplant Recipients: Results From a Real-World Survey

    Dec 1, 2025, 00:00

  • EPH157 Length of Stay (LOS) and Associated Healthcare Resource Use (HCRU) for a First Infusion of Axi-cel or Lisocel in Second Line for Large B-cell Lymphoma in Fran Differences Observed From Comprehensive Hospital Databases

    Dec 1, 2025, 00:00

  • RWD72 Economic Burden of Prostate Cancer Overall and by Stages Based on the French Real-World Nationwide Medico-Administrative Database (SNDS)

    Dec 1, 2025, 00:00

  • MT45 Use of AI in Breast Cancer Screening in England Has a Minimal Impact on Greenhouse Gas Emissions and May Increase Diagnostic Accuracy

    Dec 1, 2025, 00:00

  • SA94 The Impact of Early Antibacterial Therapy on ICU Patient Outcomes for Sepsis: A Causal Analysis

    Dec 1, 2025, 00:00

  • CO144 Improvements in Scalp Outcomes With Roflumilast Foam 0.3% for Psoriasis of the Scalp and Body From the Phase 3 ARRECTOR Trial

    Dec 1, 2025, 00:00

  • HPR96 Fit-for-Purpose Real-World Data: Lessons From FDA QCARD and EMA Data Quality Framework

    Dec 1, 2025, 00:00

  • EE694 The Cost-Effectiveness of Targeted-Release Form (TRF)-Budesonide for the Treatment of Adult Population With Immunoglobulin A Nephropathy (IgAN) in Greece

    Dec 1, 2025, 00:00

  • HPR211 The Next Steps Matter? New Cancer Medicines and Their Indication Extensions in Europe 2010-2020

    Dec 1, 2025, 00:00

  • HPR102 From Deficit Risk to Surplus Strength: A Revenue-Centered Analysis of Türkiye’s General Health Insurance 2015-2024

    Dec 1, 2025, 00:00

  • HTA323 The Landscape of the Use of Artificial Intelligence and Machine Learning (AIMI) Methods in Health Technology Assessment (HTA) Submissions

    Dec 1, 2025, 00:00

  • MSR111 From Complex Statistics to Clinically Meaningful Insights: Interpreting Results in Meta-Analyses of Continuous Outcomes

    Dec 1, 2025, 00:00

  • EPH210 Sedative-Hypnotic Drug Use and Polypharmacy Patterns Associated With Risk of Falls and Fractures in Older Adults by Osteoporosis Status: A Korean Nationwide Senior Cohort Study

    Dec 1, 2025, 00:00

  • PCR4 A Conceptual Framework for Enhancing the Clinical Utility of a Generic Veterinary Health-Related Quality of Life (HRQoL) Tool Vetmetrica™ Through the Addition of a Disease-Specific Module

    Dec 1, 2025, 00:00

  • HTA294 Role of Technical Engagement in NICE Process Under Proportionate Approach to Technology Appraisals

    Dec 1, 2025, 00:00

  • RWD3 A Proof of Concept Study to Build a Japanese-Based Electronic Medical Record Data Model Suited for Real-World Research

    Dec 1, 2025, 00:00

  • HTA286 Reimbursement Trends for Advanced Therapeutic Medicinal Products (ATMPs) in Europe

    Dec 1, 2025, 00:00

  • EPH236 The Health Impact of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab Treatment for High-Risk Early Stage Triple-Negative Breast Cancer (eTNBC) in Türkiye

    Dec 1, 2025, 00:00

  • HTA186 HTA League of Nations: Which Bodies Were Most Likely to Approve Submissions and for What Disease Areas?

    Dec 1, 2025, 00:00

  • HTA45 Assessing the Cost-Effectiveness of Lecanemab for Early Alzheimer's Disease Treatment: A Swiss Perspective

    Dec 1, 2025, 00:00

  • PCR172 Patient Involvement in the Development of Obesity and Weight Loss-Specific Patient-Reported Outcome Measures

    Dec 1, 2025, 00:00

  • EPH79 Epidemiology and Institutional Treatment Distribution of Patients With Myelofibrosis (MF) in Germany: Insights From a Real-World Evidence Study

    Dec 1, 2025, 00:00

  • PCR115 Health-Related Quality of Life for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan

    Dec 1, 2025, 00:00

  • EE697 The Disease Burden of Systemic Sclerosis in the Russian Federation

    Dec 1, 2025, 00:00

  • EPH142 Incidence of Intracerebral Hemorrhage in Patients With Mild Cognitive Impairment or Alzheimer’s Dementia Among United States Medicare Beneficiaries

    Dec 1, 2025, 00:00

  • EE728 The VIS1ON Horizon Scanning Model: Predicting the Evolution of Direct NHS Expenditure for Type 1 Diabetes in Italy up to 2028

    Dec 1, 2025, 00:00

  • CO224 Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of Immunotherapies for Perioperative Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2025, 00:00

  • MSR12 Accounting for the Additional Uncertainty Following Rank-Preserving Structural Failure Time Model (RPSFTM) Crossover Adjustment in Survival Analysis: A Sage Approach

    Dec 1, 2025, 00:00

  • EE158 Cost Calculator of Immunotherapies in 1L Endometrial Cancer Treatment for the Deficient Mismatch Repair, Proficient Mismatch Repair, and Intention-to-Treat Populations From the Brazilian Private Healthcare System

    Dec 1, 2025, 00:00

  • HSD63 Inequity in Public Healthcare Utilization Among Persons With Disabilities in Bangladesh: A Benefit Incidence Analysis

    Dec 1, 2025, 00:00

  • EE667 Socioeconomic Burden Among Children and Adults With Achondroplasia in Europe and Latin America

    Dec 1, 2025, 00:00

  • P41 Cost-Effectiveness Modeling of CAR-T Cell Therapies in Hematologic Malignancies: Insights From NICE and CDA-AMC Appraisals

    Dec 1, 2025, 00:00

  • HTA161 German Early Benefit Assessments and the Impact of Medical Societies: An Analysis

    Dec 1, 2025, 00:00

  • PCR60 Development of a Discrete Choice Experiment to Explore Preferences for Self-Sampling in a National UK Cervical Screening Program

    Dec 1, 2025, 00:00

  • HPR177 Review of Rare Disease Policy Developments in Europe and Türkiye 2020-2025 in the Context of Innovative Orphan Drugs

    Dec 1, 2025, 00:00

  • CO235 The Clinical and Economic Impact of the Introduction of Emicizumab as Prophylactic Treatment for Hemophilia A Patients in Greece

    Dec 1, 2025, 00:00

  • EE395 Economic Evaluations Cost and Resource Utilization in Early Triple-Negative and Low Hormone Receptor-Positive Breast Cancer: A Comprehensive Systematic Review

    Dec 1, 2025, 00:00

  • EPH68 Effect of Education Given to Nursing Students on Their Palliative Care Knowledge and Attitudes

    Dec 1, 2025, 00:00

  • EE673 Strategies for More Cost-Effective HrHPV Screening: A Simulation Study of Pooled Testing Based on Real-World Data in Low- and Middle-Income Countries

    Dec 1, 2025, 00:00

  • PCR95 Exploring the Use and Perception of Patient-Reported Outcome Evidence Among Cardiologists and Patients With Heart Failure

    Dec 1, 2025, 00:00

  • CO99 Epidemiology Treatment Patterns and Outcomes in Gestational Trophoblastic Neoplasia: A Systematic Literature Review and Gap Analysis

    Dec 1, 2025, 00:00

  • HSD112 Transforming Pediatric Type 1 Diabetes Care in Bulgaria Through Structured Patient Journey Analysis

    Dec 1, 2025, 00:00

  • MSR228 Eliciting Health State Preferences With Analytical Hierarchy Process: An Illustration With EQ-5D-5L

    Dec 1, 2025, 00:00

  • EE632 Quantifying the Value of Information in Early Stage Health Technology Assessment: Guiding Investment in Evidence Generation

    Dec 1, 2025, 00:00

  • EE347 Early Economic Modeling of Mutant TNF (mutTNF) As a BBB-Permeabilizing Adjunct in Breast Cancer Brain Metastases: A UK NHS Perspective

    Dec 1, 2025, 00:00

  • EE363 Economic Burden Of Primary Biliary Cholangitis (PBC) in Spain

    Dec 1, 2025, 00:00

  • HPR150 Optimizing Pricing Models for Weight-Based and Multistock-Keeping Unit (SKU) Therapies in the EU4

    Dec 1, 2025, 00:00

  • HPR40 Building Risk-Sharing Agreements in Chile: Feasibility and Policy Options

    Dec 1, 2025, 00:00

  • PCR110 Health Utility Values in Adults With Primary Biliary Cholangitis: A Global Systematic Literature Review

    Dec 1, 2025, 00:00

  • PCR126 Identifying Patient-Reported Outcome Measures to Capture Patients’ Experiences of Symptoms and Impacts of Acute Myeloid Leukemia (AML)

    Dec 1, 2025, 00:00

  • MSR106 extRpolateS: A Shiny-Based Interactive Platform for Time-to-Event Data Modeling in Health Technology Assessments

    Dec 1, 2025, 00:00

  • EE344 Drivers of Inpatient Costs in Oncology Patients Undergoing Major Abdominal Surgery: Evidence from a Middle-Income Country

    Dec 1, 2025, 00:00

  • EPH31 Budget Impact of an Organized Diabetes Screening in High-Risk Populations in France

    Dec 1, 2025, 00:00

  • HTA200 Individual Therapy or No Therapy at All: Impact of Patient Individual Therapies As ACT in the German AMNOG Process

    Dec 1, 2025, 00:00

  • P39 Seeking Patient and Public’s Opinions to Determine Target Differences in Clinical Trials: A Scoping Review of Elicitation Methods

    Dec 1, 2025, 00:00

  • MSR70 Development and Assessment of a Portability Strategy for Computable Operational Definitions

    Dec 1, 2025, 00:00

  • HSD16 Burden of Disease and Healthcare Resource Use in Patients With Hereditary Transthyretin Amyloidosis in Spain: Findings From the OverTTuRe Global Study

    Dec 1, 2025, 00:00

  • HPR148 Navigating Three Systems: A Comparative Analysis of Pharmaceutical Reimbursement in Germany, Austria, and Switzerland

    Dec 1, 2025, 00:00

  • HTA31 Analysis of HTA Decisions in Five European Countries for High Medical Need Products Approved by EMA

    Dec 1, 2025, 00:00

  • PCR139 Informing Health System Reform Through Patient Perspectives: Saudi Arabia’s OECD Paris Survey Results

    Dec 1, 2025, 00:00

  • MSR43 Automation-Only Is NOT AI: Beware, HEOR Colleagues

    Dec 1, 2025, 00:00

  • P12 Work Productivity Loss in Individuals Due to Respiratory Infections: A Questionnaire Survey of Employees in Denmark

    Dec 1, 2025, 00:00

  • MSR173 Projected Rapid-Growing Economic Burden of Chronic Respiratory Multimorbidity in Singapore: Unveiling Diagnostic Gaps and Asian Phenotypes Through Health Administrative Data

    Dec 1, 2025, 00:00

  • MSR218 Validating the Use of Large Language Models to Generate Individual Patient-Level Data for Use in Health Technology Assessment

    Dec 1, 2025, 00:00

  • EE401 Economic Impact of Poison Control Center Interventions on Hospitalization Costs in Algeria: A Retrospective Analysis

    Dec 1, 2025, 00:00

  • EE732 To Be or Not to Be Willing to Pay

    Dec 1, 2025, 00:00

  • EE321 Design and Early Insights From the Pre-HDBOI Study: A Multicountry Real-World Assessment of the Burden in Pre-Motor Manifest Huntington’s Disease

    Dec 1, 2025, 00:00

  • HTA261 Organizational Readiness for EU HTA: Early Learnings and Key Considerations for Successful Market Access

    Dec 1, 2025, 00:00

  • HPR139 Maximizing Profits Through Pricing: Opportunities in Portugal's Pharma Sector

    Dec 1, 2025, 00:00

  • CO175 Overall Treatment Landscape of Mucosal Melanoma

    Dec 1, 2025, 00:00

  • HTA367 What Is the Impact of Patient Voice on NICE Recommendations for Drugs Assessed in 2024?

    Dec 1, 2025, 00:00

  • HTA209 Integrating Real-World Evidence Into Oncology HTA Submissions: Recent EU Examples

    Dec 1, 2025, 00:00

  • EPH225 Systematic Review on the Association of Loneliness and Social Isolation With Diabetes Mellitus

    Dec 1, 2025, 00:00

  • P6 Potential Modifiers of Cost-Effectiveness Thresholds: Public Perspectives on Prioritization in Healthcare Spending

    Dec 1, 2025, 00:00

  • PCR212 Satisfact-Home: Perception of Care Quality and Quality of Life in Patients With Solid Tumors Receiving Immune Checkpoint Inhibitors (ICIs) Therapy From Hospital To Home: A French Multicenter Prospective Observational Study

    Dec 1, 2025, 00:00

  • SA25 Cross-Sectional Cohort Design Offers an Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)

    Dec 1, 2025, 00:00

  • P34 Carbon Footprint Associated With Severe Asthma Care Before and After Benralizumab Initiation: BENEFIT Study

    Dec 1, 2025, 00:00

  • P54 Thus SPOKE the TA: Querying NICE Technology Assessments Using Generative AI and RAG

    Dec 1, 2025, 00:00

  • HTA266 Patient Preference Studies in HTA for Rare Diseases: A Cross-Country Analysis of EU-4, UK, and Canada

    Dec 1, 2025, 00:00

  • RWD114 Late Treatment in Adults With Neurogenic Bowel Dysfunction: A Retrospective Analysis of German Claims Data

    Dec 1, 2025, 00:00

  • EE63 Assessing the Socioeconomic Value of Ocrelizumab Subcutaneous for Treating Relapsing Multiple Sclerosis in the Evolving Treatment Landscape in the United Kingdom

    Dec 1, 2025, 00:00

  • EE83 Budget Impact Analysis of Early FGFR3 Testing in Metastatic Urothelial Carcinoma: A Finnish Healthcare Perspective

    Dec 1, 2025, 00:00

  • P19 Treatment Burden and Quality of Life in Patients With nAMD and DME in Colombia: A Mixed Methods Study

    Dec 1, 2025, 00:00

  • EE663 Societal Impact Analysis of Introducing Elexacaftor Tezacaftor Ivacaftor (ELX TEZ IVA) in the Management of People With Cystic Fibrosis in Germany: A Paid and Unpaid Work Productivity Approach

    Dec 1, 2025, 00:00

  • HPR79 Evolution in Hospital Bed Capacity in Hungary and Romania Between 1980 and 2020 With Special Focus on Regions Inhabited by Ethnic Minorities

    Dec 1, 2025, 00:00

  • PCR243 The SISAQOL-IMI Recommendations on Standardizing the Use of Thresholds for Interpretation of Patient-Reported Outcome Results in Cancer Clinical Trials

    Dec 1, 2025, 00:00

  • EE555 Inpatient Burden of Influenza and Influenza-Like Illness Among Adults Aged 60 and Older in Germany 2019-2024

    Dec 1, 2025, 00:00

  • HTA34 Analytical Modeling in Economic Evaluations of Obesity Interventions to Inform Health Policy: A Narrative Review

    Dec 1, 2025, 00:00

  • RWD35 Clinical Relevance of a Machine Learning Model for Automated Analyses of Depression Severity: The ePHQ-9 in Treatment-Resistant Depression

    Dec 1, 2025, 00:00

  • EPH207 Reported Herpes Zoster Incidence Rates in Immunocompromised Adults Aged 18 Years or Older in England by Ethnicity and Socioeconomic Status: A Large Retrospective Cohort Study

    Dec 1, 2025, 00:00

  • EPH226 Tendencies in the Public-Funded Hungarian One-Day Surgical Care

    Dec 1, 2025, 00:00

  • HTA42 Artificial Intelligence in Pharmaceutical Payer Decision Making—Assessing Current Use, Strategic Intent, and Infrastructure Readiness

    Dec 1, 2025, 00:00

  • EE392 Economic Evaluations of Individual Service and Training Interventions for Self-Harm and Suicide Prevention: A Systematic Review

    Dec 1, 2025, 00:00

  • CO163 Matching-Adjusted Indirect Comparison of Obecabtagene Autoleucel vs. Blinatumomab Inotuzumab Ozogamicin and Ponatinib in Relapsed or Refractory Adult B-cell Acute Lymphoblastic Leukemia

    Dec 1, 2025, 00:00

  • MSR226 Workforce Matters: Defining Labor Input for Better Health Technology Assessment

    Dec 1, 2025, 00:00

  • HTA88 Confidential Prices in NICE Health Technology Assessment: How Common Are They?

    Dec 1, 2025, 00:00

  • CO208 Real-World Outcomes From a Pharmacy-Based Awareness and Screening Campaign for HF and CKD: Insights From the Chronic Diseases From A to Z Program

    Dec 1, 2025, 00:00

  • EE658 Societal and Economic Impact of Immunotherapy for NSCLC Treatment in Bulgaria

    Dec 1, 2025, 00:00

  • HPR169 Randomized Controlled Trials (RCTs) Are the Gold Standard: Are They Always Used?

    Dec 1, 2025, 00:00

  • HSD72 Mapping the Landscape of Digital Healthcare Services Delivered by Specialized Oncology Hospitals in China: Qualitative Analytical Study

    Dec 1, 2025, 00:00

  • HTA102 Decoding the Future: How Are HTA Agencies Evaluating AI in Healthcare?

    Dec 1, 2025, 00:00

  • HTA48 Assessment of the Inclusion and Importance of Carer Quality of Life in Global Health Technology Appraisals

    Dec 1, 2025, 00:00

  • RWD15 Air Pollution Signals and National Demand for Asthma Medication in Brazil Between 2018-2023: Should It Be Considered a Public-Health Concern?

    Dec 1, 2025, 00:00

  • HSD3 Access to Decide on a Generalization: Results From the EVA-Corse Experiment: Efficiency and Clinical Non-Inferiority of a Hybrid Cardiac Rehabilitation Model in Corsica

    Dec 1, 2025, 00:00

  • EE415 Establishing Robust and Adaptive Willingness-to-Pay Thresholds for Taiwan's National Health Insuran A Case Study of Non-Small Cell Lung Cancer

    Dec 1, 2025, 00:00

  • HTA360 What Counts? Exploring Stakeholder Perspectives on the Value of Guiding Criteria for Prioritizing Public Funding of Health Technologies

    Dec 1, 2025, 00:00

  • EE558 Integrating Stakeholder Willingness-to-Pay Using the Van Westendorp Price Sensitivity Meter Into Cost-Effectiveness Analysis: A Mixed-Methods Pricing Framework

    Dec 1, 2025, 00:00

  • EE207 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 1 Diabetes in Sweden: A National Real-World Evidence Perspective

    Dec 1, 2025, 00:00

  • EPH12 An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Osteoarthritis Using the THIN Dataset

    Dec 1, 2025, 00:00

  • CO21 Association Between Invasive Disease-Free Survival/Distant Recurrence-Free Survival and Overall Survival in Patients With Early Stage Triple-Negative Breast Cancer

    Dec 1, 2025, 00:00

  • HSD56 Healthcare Costs in Older Adults: XGBoost, NNA, and Logit

    Dec 1, 2025, 00:00

  • EPH147 Inequality in Vaccine Uptake: Lessons Learned From Denmark Analyzing Real-World Data From National Registries

    Dec 1, 2025, 00:00

  • EPH43 Characterizing Polycystic Ovary Syndrome (PCOS) and Related Diagnoses Using a Large US Electronic Health Records Database Linked to Claims, 2020-2025

    Dec 1, 2025, 00:00

  • PCR47 Collecting Patient Preference Information (PPI) in In-Trial/Exit Interviews: Current Perspectives and Future Considerations

    Dec 1, 2025, 00:00

  • MSR29 Application of Network Meta-Analysis in Vaccine Research: An Illustration Using Immunogenicity of Pneumococcal Vaccines in Adults

    Dec 1, 2025, 00:00

  • EE723 The Societal Value of Lecanemab for Patients With Early Alzheimer's Disease in Japan

    Dec 1, 2025, 00:00

  • MT23 Health Economic Evaluation Model for Breast Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)

    Dec 1, 2025, 00:00

  • MSR208 Uncovering Patient Narratives of Opioid Use and Recovery Using Large Language Models for Topic and Emotion Analysis of Social Media Discussions

    Dec 1, 2025, 00:00

  • EPH27 Beyond the Guidelines: Exploring the Characteristics and Comorbidity Profiles of Adults With Pneumococcal Disease in England Not Covered by Current Pneumococcal Vaccination Criteria

    Dec 1, 2025, 00:00

  • EE626 Quantifying the Economic Impact of Flexible Endoscope-Related Procedure Rescheduling in NHS Endoscopy Services: A Retrospective Analysis and Survey-Based Model

    Dec 1, 2025, 00:00

  • EE85 Budget Impact Analysis of GLP-1 Receptor Agonists for Type 2 Diabetes Management in India

    Dec 1, 2025, 00:00

  • EE157 Cost and Healthcare Resource Utilization Associated With Chronic Inducible Urticaria: A Targeted Literature Review

    Dec 1, 2025, 00:00

  • PCR49 Comparing Health-Related Quality of Life in Obese Patients With and Without Bariatric Surgery: A Cross-Sectional Study in a Multi-Ethnic Asian Population in Singapore

    Dec 1, 2025, 00:00

  • MSR136 Leveraging Generative Artificial Intelligence for the Creation of Global Value Dossiers Through a RAG Pipeline and Multi-Agent Integration

    Dec 1, 2025, 00:00

  • HTA223 Limited Access to Joint Scientific Consultations in 2025: Strategic Impact on Industry and Policy Directions for Sustainable EU HTA Implementation

    Dec 1, 2025, 00:00

  • MSR193 Synthetic Data Generation Methods Using Artificial Intelligence (AI): A Simple New AI Tool That Generates Synthetic Data Using Generative Adversarial Network (CTGAN), Copula GANs, and Sequential Decision Tree Methods

    Dec 1, 2025, 00:00

  • RWD43 Comprehensive Landscape Assessment of Real-World Databases for HEOR Studies in the Asia-Pacific Region: A Growing Opportunity

    Dec 1, 2025, 00:00

  • HSD32 Describing the Real-World Burden of Demodex Blepharitis: A Multicenter Audit in a UK Public Specialist Eye-Care Setting

    Dec 1, 2025, 00:00

  • EPH246 The Incidence Mortality and Survival of Malignant Hematopoietic Neoplasms in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2000-2022 Database Analysis

    Dec 1, 2025, 00:00

  • EE116 Burden of Disease in Hereditary Transthyretin Amyloidosis With Polyneuropathy in Spain

    Dec 1, 2025, 00:00

  • CO147 Improving Pulmonary Tuberculosis Treatment Outcomes Through Pharmacist-Led Education: Findings From a Malaysian Randomized Control Trial

    Dec 1, 2025, 00:00

  • HSD1 A Case Study Demonstrating the Utility of the High-Tech Hub Electronic Prescribing Facility to Identify Off-Label Prescribing

    Dec 1, 2025, 00:00

  • MSR159 Optimizing Patient Retention in Non–Site-Based Longitudinal Studies: Tailored Follow-up Strategies for Rare Disease Cohorts

    Dec 1, 2025, 00:00

  • CO189 Primary Lateral Sclerosis (PLS): A Targeted Literature Review of Symptoms, Progression, and Outcomes to Inform Evidence Gaps for Rare Neurological Disorders

    Dec 1, 2025, 00:00

  • CO55 Comparative Efficacy and Safety of Delgocitinib, Alitretinoin, and PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema: A Network Meta-Analysis

    Dec 1, 2025, 00:00

  • EPH152 Ischemic Stroke in Europe: Incidence Trends Over Three Decades (1991-2021)

    Dec 1, 2025, 00:00

  • CO192 Projected Public Health Benefits of Nirsevimab for RSV Prevention in Infants in Greece

    Dec 1, 2025, 00:00

  • EE192 Cost-Consequence and Clinical Impact of NGS Testing in Advanced Lung Adenocarcinoma: Real-World Evidence From a Portuguese Public Hospital

    Dec 1, 2025, 00:00

  • PCR76 EQ-5D Utility Trends in NMOSD: Impact of Time and Disability

    Dec 1, 2025, 00:00

  • HPR226 Uncertainties in Regulatory Benefit-Risk Decision Making for Innovative Anticancer Therapies: Preliminary Results From a 2011-2024 Review of Extensions of Indications

    Dec 1, 2025, 00:00

  • PCR151 Mapping the Evidence on Interrelationships Between Cancer Stage Financial Toxicity (FT) and Health-Related Quality of Life (HRQoL)

    Dec 1, 2025, 00:00

  • HTA117 Dutch Cost Implications of Faricimab in Neovascular Age-Related Macular Degeneration: A Systematic Review of Treatment Interval and Injection Frequency

    Dec 1, 2025, 00:00

  • EPH253 The Relevance of the Use of TENS Devices in the Therapy of Poststroke Dysphagia

    Dec 1, 2025, 00:00

  • HTA20 Activity of the French Economic and Public Health Evaluation Committee (CEESP): Retrospective of 10 Years of Economic Assessment on Health Products

    Dec 1, 2025, 00:00

  • MSR119 How Can the Threshold Method Guide the Choice of Treatments? Illustration in French Patients With Hemophilia A or B

    Dec 1, 2025, 00:00

  • MSR143 Matching Adjusted Indirect Comparison of Asciminib vs. Flumatinib as First-Line Treatment for Chronic Myeloid Leukemia in China

    Dec 1, 2025, 00:00

  • MSR192 Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods

    Dec 1, 2025, 00:00

  • HSD60 Humanistic and Financial Burden Experienced by Nonprofessional Care Partners of Patients With Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease: Results From a Real-World Survey in Spain

    Dec 1, 2025, 00:00

  • PCR251 Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in the Netherlands: Insights From CHOICE-CSU 2 Study

    Dec 1, 2025, 00:00

  • HTA227 Mapping Writer-AI Conversations for HTA: Preliminary Analysis of 7009 Messages

    Dec 1, 2025, 00:00

  • EPH40 Characterizing the Use of Janus Kinase Inhibitors (JAKi) in Five European Countries: A Drug Utilization Study

    Dec 1, 2025, 00:00

  • PCR11 A Systematic Review of Trends From Migraine Preference Studies

    Dec 1, 2025, 00:00

  • MSR19 AI Models for Predicting Clinical Trial Success: Capabilities and Risks of Pattern-Driven Approaches

    Dec 1, 2025, 00:00

  • HPR126 Integrating Guidance Through a Whole Life-Cycle Approach: Wouldn’t It Be NICE?

    Dec 1, 2025, 00:00

  • EE563 Launch Price Dynamics of Targeted Therapies in NSCLC: Dissecting the Cost and Value Across Biomarker Segments

    Dec 1, 2025, 00:00

  • HPR78 Evaluation of the Implementation Effect of Medical Service Price Reforms: A Case Study of Assisted Reproductive Services in China

    Dec 1, 2025, 00:00

  • EE500 Healthcare Costs in People With Type 2 Diabetes Remaining on or Escalating From Basal-Supported Oral Therapy: A 5-Year German Statutory Health Insurance Claims Data Analysis

    Dec 1, 2025, 00:00

  • PCR236 The Mediating Role of Insomnia in the Relationship Between Disease Severity and Mental Health Quality of Life and Productivity in Atopic Dermatitis

    Dec 1, 2025, 00:00

  • RWD151 Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Atopic Dermatitis in Poland in Comparison With Efficacy Reported in Clinical Trials

    Dec 1, 2025, 00:00

  • RWD79 Evaluation of Real-World Data Landscape in the United Kingdom: A Scoping Review

    Dec 1, 2025, 00:00

  • HTA132 Evaluating High-Cost Gene Therapies for Noncancer Conditions: Insights From NICE's Standard Appraisal Process

    Dec 1, 2025, 00:00

  • PCR217 Social Determinants of Health Affecting Response to Opioid Addiction Treatment

    Dec 1, 2025, 00:00

  • HSD89 Population-Level Impact Assessment of the Revised Dyslipidemia Prescription Protocol in Greece Using Simulation Modeling

    Dec 1, 2025, 00:00

  • HTA127 Equality Considerations in NICE Guidance of Medical Devices Digital and Diagnostic Technologies and Interventional Procedures

    Dec 1, 2025, 00:00

  • RWD150 Real-World Characterization of Urticaria Subtypes in Brazil: A TriNetX-Based Analysis of Demographics, Comorbidities, Treatments, and Laboratory Markers

    Dec 1, 2025, 00:00

  • EE624 Quantification of Life-Cycle Value Using Early Modeling to Support RD and Strategy Decisions: A Case Study of a Polymeric Heart Valve

    Dec 1, 2025, 00:00

  • P56 An Early Start: Preliminary Indirect Treatment Comparison Assessments Informing Evidence-Generation Planning for Joint Clinical Assessment

    Dec 1, 2025, 00:00

  • HSD47 Evaluating the Validity of Immunotherapy in Retreatment and Rechallenge Strategies for Oncology Patients

    Dec 1, 2025, 00:00

  • EE494 Health Economic Modeling Approaches for Assessing the Value of a Clostridioides Difficile Vaccination Program: A Literature Review

    Dec 1, 2025, 00:00

  • EE492 Health Economic Evaluation Model for Prostate Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)

    Dec 1, 2025, 00:00

  • MSR115 Generation of Synthetic Patient Data to Overcome Machine Learning Limitations in Healthcare Research: A Systematic Review of Methods, Performance, and Use Cases

    Dec 1, 2025, 00:00

  • EE212 Cost-Effectiveness Analysis of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for Patients With High-Risk Early Stage Triple-Negative Breast Cancer in Chile

    Dec 1, 2025, 00:00

  • MSR132 Instrumental Variable Treatment Effects Estimation: A Simulation Comparison of Instrumental Variables and OLS Approaches

    Dec 1, 2025, 00:00

  • PCR156 Measuring the Disease Burden and Quality of Life From the Schizophrenia Caregivers’ Perspective

    Dec 1, 2025, 00:00

  • EE639 Real-World Healthcare Resource Utilization in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Tipiracil Plus Bevacizumab or With Regorafenib

    Dec 1, 2025, 00:00

  • PT2 Frequency and Impact of External Comparator Arms in Oncology HTA Assessments With Single-Arm Trials in the UK, France, and Germany From 2014 to 2024

    Dec 1, 2025, 00:00

  • PCR116 Health-Related Quality of Life in Firstline Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review With Focus on the PD-L1 Negative Subgroup

    Dec 1, 2025, 00:00

  • EPH3 A Critical Review of the Screening Criteria Ratings and Recommendations by the UK National Screening Committee (NSC) for 30 Adult Conditions

    Dec 1, 2025, 00:00

  • HPR94 Feasibility of Indication-Specific Pricing for Life Cycle Management of an Innovative Rare Disease Product

    Dec 1, 2025, 00:00

  • PT11 High Entry Costs Slower Growth: A Nationwide Register Study on Newly Reimbursed Biologic Medicines in Finland 2011-2021

    Dec 1, 2025, 00:00

  • EPH200 Quality of Life of Patients Living With Epilepsy in Hungary

    Dec 1, 2025, 00:00

  • MSR96 Evaluating the Reliability of Value of Information Methods: A Simulation-Based Comparison

    Dec 1, 2025, 00:00

  • PCR248 Treatment Patterns and Healthcare Resource Utilization Among Patients With Immune Thrombocytopenia: A Real-World Survey

    Dec 1, 2025, 00:00

  • HTA228 Market Access 2030: AI-Driven Dossier Transformation and Therapeutic Value Communication Across Global Health Systems

    Dec 1, 2025, 00:00

  • RWD55 Deep Real-World Analysis of Patients With Myelofibrosis Using Natural Language Processing and Machine Learning: A Methods Description

    Dec 1, 2025, 00:00

  • EPH167 Multi-Level Factors Influencing Active Surveillance Initiation Among Elderly Medicare Beneficiaries Newly Diagnosed With Low-Risk and Favorable Intermediate-Risk Prostate Cancer: An Active Comparator New User Retrospective Cohort Stu ...

    Dec 1, 2025, 00:00

  • HTA289 Review of Surrogate Endpoints’ Acceptance Trends in German HTA and Implications for EU Joint Clinical Assessment

    Dec 1, 2025, 00:00

  • SA61 Leveraging AI for Evidence Synthesis: Assessing the Accuracy and Efficiency of AI-Supported Data Extraction and Reporting

    Dec 1, 2025, 00:00

  • CO59 Comparative Efficacy Safety and Discontinuation of Inhaled Levodopa for Patients With Parkinson’s Disease: A Network Meta-Analysis

    Dec 1, 2025, 00:00

  • SA42 Feasibility Assessment of a Real-World Comparator Cohort Using Multiple Qualifying Index Lines of Therapy (LOTs) in Third-Line or Later (3L+) Diffuse Large B-cell Lymphoma (DLBCL)

    Dec 1, 2025, 00:00

  • EE129 Clinical and Economic Burden Imposed by Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Belgium

    Dec 1, 2025, 00:00

  • RWD120 Making Health Data Trustees Sustainable: An Overview of Potential Business and Financing Models

    Dec 1, 2025, 00:00

  • EE135 Comparative Analysis of Pan-European Severity Assessment Methods and Their Uncertainty in Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • MSR49 Bridging the Survival Extrapolation Gap in Health Economic Models: A Case Study on Spline-Based Survival Analysis Using ML-NMR to Address Complex Hazard Function

    Dec 1, 2025, 00:00

  • MSR205 Transportability of Overall Survival Estimates From the United States to Germany in eGFR+ Advanced NSCLC Patients Post-Tyrosine Kinase Inhibitor (TKI) Treatment

    Dec 1, 2025, 00:00

  • HSD88 Physician Perspectives on Unmet Need and Treatment Options Among Patients With Relapsed Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Canada: Findings From Qualitative Interviews

    Dec 1, 2025, 00:00

  • HSD13 Barriers and Enablers in Health System Redesign

    Dec 1, 2025, 00:00

  • CO74 Dinutuximab Beta vs. Historical Controls in the Maintenance Therapy of Relapsed Neuroblastoma: Unadjusted and Adjusted Indirect Comparison

    Dec 1, 2025, 00:00

  • HTA284 Reimbursement Challenges for ATMPs in EU5: Learnings From Product Withdrawals and Implications for Future Development of Innovative Therapies

    Dec 1, 2025, 00:00

  • CO222 Survival Outcomes in People Living With HIV Who Experienced Progressive Multifocal Leukoencephalopathy Compared to the General Population

    Dec 1, 2025, 00:00

  • EPH49 Comorbidities of Anxiety Disorders in Children and Adolescents in Germany: A Nationwide Representative Claims Data Analysis

    Dec 1, 2025, 00:00

  • PCR267 What Affects Quality of Life Most in Oral Cancer Therapy? A Pilot Study of Adherence and Side Effects

    Dec 1, 2025, 00:00

  • HTA213 Italian Perspective on Rare Disease New Treatments and HTA: Insights From Iptacopan Multidimensional Evaluation in PNH

    Dec 1, 2025, 00:00

  • EE128 Clinical and Economic Burden Among Patients Requiring Long-Term Intermittent Catheter Use in England: A Real-World Retrospective Observational Cohort Study

    Dec 1, 2025, 00:00

  • RWD1 A Description of the Incidence and Burden of Hyperkalemia in Irish Hospitals 2022-2024

    Dec 1, 2025, 00:00

  • HTA57 Bridging National and EU HTA Regulation: Policy Responses to the JCA Rollout

    Dec 1, 2025, 00:00

  • EPH24 Associations Between Waiting Time and Treatment Completion Among Treatment-Naive Pregnant Cannabis Users Admitted to Treatment Facilities in the United States

    Dec 1, 2025, 00:00

  • EE609 Piloting Structured Expert Elicitation: An Exploratory Case Study of Practical Implementation

    Dec 1, 2025, 00:00

  • SA33 Developmental Rehabilitation in Children With Autism: Utilization and Economic Burden in South Korea

    Dec 1, 2025, 00:00

  • HPR67 Effect of the Inflation Reduction Act on Drug Innovation

    Dec 1, 2025, 00:00

  • EE733 Transfusion-Related Cost and Time Burden in JAKi-Naïve and JAKi-Experienced Patients With Myelofibrosis Treated With Momelotinib and Ruxolitinib From the SIMPLIFY 1 and 2 Studies: A Brazilian Supplementary Health Perspective

    Dec 1, 2025, 00:00

  • CO180 Pillcam COLON 2 for Investigation of the COLON Through Direct Visualization: A Systematic Review

    Dec 1, 2025, 00:00

  • EE370 Economic Evaluation in Alzheimer’s Disease: A Systematic Review

    Dec 1, 2025, 00:00

  • EE279 Cost-Effectiveness of T-DM1 vs. Trastuzumab for Adjuvant Treatment in HER2 Early Breast Cancer (eBC) With Residual Disease in Colombia

    Dec 1, 2025, 00:00

  • EE340 Do We Need to Measure Social Impact of Innovative Drugs?

    Dec 1, 2025, 00:00

  • EE457 Exploring LLMs in the Conceptual and Functional Construction of Health Economic Models: A Case Study on Alzheimer's Diagnostic Cost-Effectiveness Model

    Dec 1, 2025, 00:00

  • HSD117 Trends and Economic Impact of Medication Errors in Public Hospitals of Eastern Region Ghana: A Retrospective Analysis From 2018 to 2024

    Dec 1, 2025, 00:00

  • MSR53 Can Generative Artificial Intelligence (GenAI) Be Leveraged to Automate Scoping Searches of Systematic Literature Reviews (SLRs)?

    Dec 1, 2025, 00:00

  • EE211 Cost-Effectiveness Analysis of Lebrikizumab vs. Alternative Biologics in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis in the UK

    Dec 1, 2025, 00:00

  • HPR183 Shortage of Antineoplastics and Supportive Medicines in Armenia

    Dec 1, 2025, 00:00

  • EE393 Economic Evaluations of Medical Interventions for Adult People Living With Obesity: Protocol for a Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE53 Early Outpatient Follow-up and Reduced Health Care Resource Utilization in Acute Heart Failure in Germany: A Descriptive Analysis

    Dec 1, 2025, 00:00

  • EE430 Evaluating Cost Benefits of Subcutaneous vs. Intravenous Trastuzumab/Pertuzumab in HER2-Positive Early Breast Cancer Patients: From Qatari Healthcare Perspective

    Dec 1, 2025, 00:00

  • EE9 A Cost-Effectiveness Analysis of Abrocitinib vs. Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis

    Dec 1, 2025, 00:00

  • HTA304 Subsequent Treatments and NICE Appraisals for DLBCL: A Review of Committee Discussions

    Dec 1, 2025, 00:00

  • EPH164 Molecular Testing Strategies and Their Impact on Treatment Decision in HR+/HER2- Metastatic Breast Cancer: A Real-World Analysis From German Centers

    Dec 1, 2025, 00:00

  • EE318 Decision-Analytic Modeling on Imaging Modalities in Breast Cancer Staging: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE36 A Systematic Review of Using Social Return on Investments Within Healthcare Service Evaluations: Methodological Opportunity and Challenges

    Dec 1, 2025, 00:00

  • EE132 Clinical and Economic Perspectives on Influenza and COVID-19 Vaccine Combinations

    Dec 1, 2025, 00:00

  • MSR90 Evaluating an Automated AI-Driven Pipeline for Literature Surveillance and Synthesis: A Proof-of-Concept for Health Economics and Outcomes Research (HEOR) Communications

    Dec 1, 2025, 00:00

  • EE168 Cost-Effectiveness of Belatacept as Conversion Therapy in the Management of Patients Living With a Renal Graft in France

    Dec 1, 2025, 00:00

  • HSD70 Mapping Anatomic Pathology Laboratories of Public Hospitals in Gree Units, Infrastructure, Personnel, and Workload Estimation

    Dec 1, 2025, 00:00

  • EE27 A Prevalence-Weighted ICER Approach With Scenario Analyses for HTA Without RCT Evidence

    Dec 1, 2025, 00:00

  • HSD119 Understanding Trends and Opinions on More Environmentally Friendly Healthcare: A Clinician Survey

    Dec 1, 2025, 00:00

  • HTA255 NICE Reduces Waiting Times for Technology Adoption: Early Value Assessment As a Pragmatic Approach to Adopting Promising Innovation in the NHS

    Dec 1, 2025, 00:00

  • SA63 Lung-Cancer Diagnostic Trajectories: A Nationwide Process-Mining Cluster Analysis of 18,569 French Patients

    Dec 1, 2025, 00:00

  • Impact of Constrained Access to Primary Care on Health-Related Quality of Life

    Dec 1, 2025, 00:00

  • PCR186 Perspectives of Patients and Healthcare Providers on a Shared Decision-Making Dashboard in Rheumatoid Arthritis Care

    Dec 1, 2025, 00:00

  • EE10 A Cost-Effectiveness Analysis of First-Line Therapies for Microsatellite-Instability-High (MSI-H) or Mismatch-Repair-Deficient (dMMR) Unresectable or Metastatic Colorectal Cancer (mCRC) in France

    Dec 1, 2025, 00:00

  • EPH160 Measurement of Functional Outcome Using the Modified Rankin Scale in Patients With Acute Ischemic Stroke

    Dec 1, 2025, 00:00

  • HPR145 Navigating Implementation of the EU HTA Regulation for Medical Devices: Insights From National HTA Bodies Across Europe

    Dec 1, 2025, 00:00

  • PT31 Systemic Solutions Influencing Physicians' Prescription Behavior Leading to Savings in the Reimbursement Budget in European Countries: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • PCR226 The EB Insights Study: The Impact of Epidermolysis Bullosa on Carer Health-Related Quality of Life

    Dec 1, 2025, 00:00

  • CO22 Association Between Nonvalvular Atrial Fibrillation Type and Therapeutic Failure in Hospitalized Patients With History of Atrial Fibrillation Admitted to a Stepdown Unit

    Dec 1, 2025, 00:00

  • EPH186 Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs

    Dec 1, 2025, 00:00

  • SA41 Factors Associated With the Publication of Real-World Evidence Studies in Lung Cancer by Journal Impact Factor

    Dec 1, 2025, 00:00

  • MT17 From Anxiety to Hope: Understanding the Adoption of AI Counseling Tools for Anxiety Management

    Dec 1, 2025, 00:00

  • HTA183 HTA and Regulatory Perspectives on Robustness of Evidence and Management of Uncertainties

    Dec 1, 2025, 00:00

  • HTA346 Understanding the Impact of Equality and Equity Considerations on NICE Highly Specialized Technology (HST) Decision Making

    Dec 1, 2025, 00:00

  • EE565 Lifetime Secondary Healthcare Resource Utilization in Phenylketonuria From Birth to Adulthood in Sweden

    Dec 1, 2025, 00:00

  • EE62 Assessing the Health-Related Quality of Life and Economic Burden of Dry Eye Disease in Thailand: A Multi-Center Study on Patient-Reported Outcomes

    Dec 1, 2025, 00:00

  • HTA73 Challenges in the German AMNOG Procedure: The Need for National PICO Transparency and Optimized Consultation Windows in the Context of EU-HTA

    Dec 1, 2025, 00:00

  • CO218 Semaglutide Weight Outcomes Among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Real-World Setting

    Dec 1, 2025, 00:00

  • EE601 Optimizing HER2+ Breast Cancer Treatment Pathways in Italian Oncological Centers

    Dec 1, 2025, 00:00

  • EE517 Healthcare Resource Utilization for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan

    Dec 1, 2025, 00:00

  • EE496 Healthcare and Economic Burden of Intravenous and Subcutaneous Immunoglobulin Treatment in Three Autoimmune Neuromuscular Diseases: A Bicentric Spanish Experience

    Dec 1, 2025, 00:00

  • SA3 A Scoping Review of Resource Modeling in HTA Using Discrete Event Simulation

    Dec 1, 2025, 00:00

  • CO157 Investigating the Patient-Relevance of Achieving Blood Phe Thresholds in PKU: Results From an Analysis of the OPAL Study

    Dec 1, 2025, 00:00

  • EE701 The Economic Burden of Moderate and Severe Anxiety and Depression Symptoms in Saudi Arabia

    Dec 1, 2025, 00:00

  • MSR2 A Disease Progression Model Comparing Respiratory and Motor Decline in People With Late-Onset Pompe Disease Treated With Cipaglucosidase Alfa Plus Miglustat vs. Alglucosidase Alfa

    Dec 1, 2025, 00:00

  • CO245 The Mirage of Stability: Challenges of Predicting Disease Activity Over Time in Systemic Lupus Erythematosus (SLE)

    Dec 1, 2025, 00:00

  • SA31 Determining the Minimal Important Difference of EQ-5D-5L Utility Values in CIDP Patients Using Data From a Large Clinical Trial

    Dec 1, 2025, 00:00

  • MSR39 Assessing Bias in LLM-Extracted Real-World Data: A Health Equity Analysis of Access to Care and Outcomes in Metastatic Breast Cancer

    Dec 1, 2025, 00:00

  • CO240 The Impact of Dietary Supplements (Vitamin B12, Vitamin D, Magnesium) on the Quality of Life (QoL) of Users in Edessa, Northern Greece

    Dec 1, 2025, 00:00

  • MSR74 Development of Prioritization Criteria for Implementation and Further Development of HTA Methods: Results From SUSTAIN-HTA

    Dec 1, 2025, 00:00

  • HTA288 Retrospective Analysis of Hungarian HTA Submissions Under the Former National Health Economics Guideline

    Dec 1, 2025, 00:00

  • HTA112 Digital Health Technologies Assessment Based on Patient-Reported Outcome Measures (PROMs): Virtual Reality (VR) in the Treatment of Specific Phobias

    Dec 1, 2025, 00:00

  • HTA7 A Gap Analysis of HTA Methods in Europe: Results From SUSTAIN-HTA

    Dec 1, 2025, 00:00

  • HPR123 Innovation in Off-Patent Competitive Environment: Key Learnings From Successes and Failures

    Dec 1, 2025, 00:00

  • HPR16 Accessibility and Time to Reimbursement of Treatments With Substantial Benefit: A Comparative Analysis Focused on Inequalities Between Different European Countries and Different Tumor Types

    Dec 1, 2025, 00:00

  • CO252 Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework

    Dec 1, 2025, 00:00

  • HPR184 Single-Arm Trials and Reimbursement Decision Making in Europe: A Case Study in Non-Small Cell Lung Cancer

    Dec 1, 2025, 00:00

  • EE391 Economic Evaluations of First-Line Non-Small Cell Lung Cancer Therapies: A Systematic Review With Focus on PD-L1 Subgroups

    Dec 1, 2025, 00:00

  • EE714 The Impact of Inflation: A Cost Analysis in the Spanish Pharmaceutical Sector From 2014 to 2023

    Dec 1, 2025, 00:00

  • HPR171 Reframing Pharmaceutical Pricing: Implications of the 2025 SVR Report for Germany’s Pricing Logic and International Spillovers

    Dec 1, 2025, 00:00

  • CO203 Real-World Effectiveness of Systemic Therapies in Adults with KRAS(G12C) Metastatic Colorectal Cancer in Europe: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • PCR215 Shared Decision Making in Inflammatory Bowel Disease: An Observational Study Combining Patient Physician and Observer Perspectives

    Dec 1, 2025, 00:00

  • PCR120 Health-Related Quality of Life of Caregivers of Children and Adolescents With Disease in Korea

    Dec 1, 2025, 00:00

  • SA50 How Much Time Does Artificial Intelligence Really Save in Evidence Synthesis? A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE291 Costs of Breast Cancer Surgical Care in Newly Diagnosed Patients in 2015 and 2019: A French Nationwide Claims Database Study

    Dec 1, 2025, 00:00

  • EPH56 Delta Price Cost-Effectiveness Analysis of PCV21 vs. PCV20 Use in Adults Aged ≥18 Years in Austria

    Dec 1, 2025, 00:00

  • EPH1 A Comparison of the Potential Public Health Impact of PCV15 and PCV20 in French Infants

    Dec 1, 2025, 00:00

  • CO170 Network Meta-Analysis for an Efficacy Assessment of Avelumab Axitinib in the First-Line Treatment of International Metastatic RCC Database Consortium (IMDC) Favorable Risk Patients With Advanced Renal Cell Carcinoma (ARCC)

    Dec 1, 2025, 00:00

  • CO161 Management of Biliary Tract Cancer: A Modified Delphi (Consensus) Survey of UK Clinical Experts

    Dec 1, 2025, 00:00

  • EE309 Cost-Utility Analysis of the AlloMap® Test for the Monitoring of Patients After Heart Transplantation: Economic Evaluation Alongside the CUPIDON Trial

    Dec 1, 2025, 00:00

  • EE387 Economic Evaluation of Tarlatamab as Second-Line Therapy for Metastatic Small-Cell Lung Cancer: A United States Perspective

    Dec 1, 2025, 00:00

  • PT25 Systems-Level Modeling Approaches for Complex Health Technologies: A Systematic Review

    Dec 1, 2025, 00:00

  • HTA264 Patient Access Delays for Subsequent High-Value Indications of Multi-Indication Treatments: An Assessment of Health Technology Assessment Decision Making

    Dec 1, 2025, 00:00

  • OP13 Knowledge of Natural Contraception and Its Effect on the Relationship: Mobile Application

    Dec 1, 2025, 00:00

  • SA27 Data Reliability in Retrospective Chart Review Studies: Results and Considerations From a Novel Data Review Methodology

    Dec 1, 2025, 00:00

  • EE568 Long-Term Economic Impact of Nonpersistence to Disease-Modifying Therapies in a Cohort of German Patients With Multiple Sclerosis

    Dec 1, 2025, 00:00

  • EE666 Socioeconomic Burden (SOB) of Multiple Sclerosis (MS) in Latin America (LATAM): Trends and Projections 2017-2032

    Dec 1, 2025, 00:00

  • EE16 A Cost-Utility Analysis of Ferric Derisomaltose vs. Ferric Carboxymaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease in the United Kingdom: Accounting for Difference in Fracture Risk

    Dec 1, 2025, 00:00

  • HTA316 The Greek Drug Price Negotiation Committee and Its Contribution in Optimizing the Management of EOPYY's Pharmaceutical Budget

    Dec 1, 2025, 00:00

  • HTA363 What Generalized Cost-Effectiveness Analysis (GCEA) Reveals About the Applicability of Foreign Reference Pricing in Medicare Price Negotiation in the US

    Dec 1, 2025, 00:00

  • RWD63 Development of an LLM-Based Computable Phenotype for Pediatric Lymphoma Subtypes Using Structured and Unstructured Electronic Medical Record Data

    Dec 1, 2025, 00:00

  • Poor Patient Care Outcomes and Nurse Job Outcomes Associated With Unfavorable Intensive Care Unit and Emergency Department Nurse Work Environments: Implications for Critical Care Medicine

    Dec 1, 2025, 00:00

  • HTA177 Healthstate Utilities for Hormone Receptor-Positive (HR+) Human Epidermal Growth Factor-Receptor 2 Negative (HER2-) Breast Cancer

    Dec 1, 2025, 00:00

  • EE495 Health Utilities Among Patients With Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial

    Dec 1, 2025, 00:00

  • MSR182 Rescaled Tariff Regression for EQ-5D-5L Health State Valuation: An Equivalent Alternative to the Nonparametric Crosswalk

    Dec 1, 2025, 00:00

  • P52 Evolution of Risk-Sharing Agreements for Orphan Drugs 2015-2024

    Dec 1, 2025, 00:00

  • EE214 Cost-Effectiveness Analysis of Oteseconazole vs. Fluconazole for Patients With Severe Vulvovaginal Candidiasis in China

    Dec 1, 2025, 00:00

  • HPR135 Managed Reimbursement of Continuous Glucose Monitoring Sensors in Ireland: Year One Review

    Dec 1, 2025, 00:00

  • EE686 The Broader Economics of Chronic Spontaneous Urticaria (CSU) in Japan: Assessing Societal and Fiscal Benefits of Novel Therapies

    Dec 1, 2025, 00:00

  • EE292 Cost-Savings Analysis of Fitusiran Prophylaxis: Reducing Breakthrough Bleeding Treatment Expenditure in the Kingdom of Saudi Arabia

    Dec 1, 2025, 00:00

  • PCR240 The Relevance of Core Outcome Sets to Improving Healthcare Decision Making

    Dec 1, 2025, 00:00

  • CO226 Systematic Literature Review (SLR) of First-Line (1L) Treatments of Patients With Advanced or Metastatic HER2-Positive Gastroesophageal Adenocarcinoma (GEA)

    Dec 1, 2025, 00:00

  • HPR130 Investigation of Patient Satisfaction With Home Nursing Care Among Recipients

    Dec 1, 2025, 00:00

  • HTA343 US Payer Assessment of the Utility and Impact of Value Dossiers on Decision Making

    Dec 1, 2025, 00:00

  • MSR68 Demonstrating the Importance of Modeling Rapid Cancer Progression in Screening Evaluations

    Dec 1, 2025, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • »